DGJR

The chemotherapy-free regimen blinatumomab and ponatinib is associated with significantly improved PFS and OS compared to Hyper-CVAD with ponatinib, with less non-relapse morality and a reduced reliance on allo-SCT in Ph+ ALL. doi.org/10.1002/ajh.70… @AjHematology @UTMDAnderson

Attending EHA2026? Explore the latest CML sessions covering TFR, new therapies, blast crisis biology, pediatric CML, resistance mechanisms, and more. The iCMLf has compiled a practical overview of key CML sessions for you. Download the overview here: buff.ly/PouK9LY

The iCMLf Clinical Trials Hub has been updated with the latest global CML clinical trial information as part of our regular update cycle. Explore recruiting and upcoming studies investigating new compounds in CML and download the latest searchable file: buff.ly/uCHnQQB

🌍 The 2026 iCMLf Prize is awarded to Ass. Prof. Amha Gebremedhin for advancing CML diagnosis, treatment, and specialist training in Ethiopia. His work has helped build sustainable hematology services and improve outcomes for patients with CML. Read more: buff.ly/K8N2Oe2

The 2026 iCMLf John Goldman Prize is awarded to Professor Meinolf Suttorp for his pioneering contributions to pediatric CML research and management. His work has shaped modern treatment strategies and improve outcomes in pediatric CML worldwide. Read more: buff.ly/E4rKRVP

🔬 The 2026 iCMLf Rowley Prize is awarded to Prof. Junia Vaz de Melo for her pioneering contributions to understanding the molecular biology of CML. Her work has advanced insights into BCR::ABL signalling, leukemic stem cells, and treatment resistance: buff.ly/wHgD0dt

We are delighted to announce the 2026 iCMLf Prize winners: 🏆 Rowley Prize – Professor Junia Vaz de Melo 🏆 Goldman Prize – Professor Meinolf Suttorp 🏆 iCMLf Prize – Associate Professor Amha Gebremedhin Learn more about their work: buff.ly/Qoz9C5D

t's Friday! Start that weekend right & register for #SOHO2026. Go to soho.click/2026 & register before those early bird rates disappear. SOHO members get 40% off registration. Become a member at soho.click/join.

Be part of #SOHO2026. Submit your abstract for oral or poster presentation today. Go to soho.click/abstracts to learn more 👍

It’s that time of the year. Abstracts are NOW OPEN for #SOHO2026! Young investigators , this is YOUR chance to present your work at one of the most dynamic, intimate hematology meetings of the year Deadline: May 15 Submit here 👉 soho.click/abstracts #HemOnc #SOHO2026 #hemepath @SocietyofHemOnc

📣#ESHCMLMPN2027: REGISTRATION & ABSTRACT SUBMISSION ARE OPEN! To proceed & for more info➡bit.ly/3Z8y3tI March 5-7, 2027/Prague, Czech Republic. 5th How to Diagnose and Treat CML/MPN Chairs: @harrisoncn1, @AndreasHochhaus, Ruben Mesa @mpdrc #ESHCONFERENCES #MPNsm #CMLsm

And thanks to our chairwomen, executive board members and audience during this hot topic #Filmc session on pregnancy by Dr Balsat, TFR by Pr Zakova and ASXL1 biology by Pr Sloma.

Thanks to our great speakers during the #Filmc session at the 46th #SFH congress, Paris

📅 Dates for Your Diary - Upcoming CML Meetings and iCMLf Events There are several important meetings and opportunities coming up for the global CML community in the months ahead. You can view the full list here: buff.ly/RQlpnbn

📣DISCOVER THE LEARNING OBJECTIVES OF #ESHCML2026 More information➡bit.ly/47owRrl ESH-#iCMLf 28th Annual John Goldman Conference on #CMLsm: Biology & Therapy October 2-4, 2026/Gothenburg, Sweden Chairs: @GCC_Cortes @timhughesCML Daniela. S. Krause #ESHCONFERENCES @icmlf

In less than two weeks, our climbers will embark on the Avenue of the Volcanoes - an 8-day trek to support CML research and patient care. Support their journey: …b-for-a-cure.raiselysite.comysite.com @novartis @TernsPharma @AscentagePharma @sahmriAU Enliven

Yesterday was World Childhood Cancer Day. CML in children is rare - paediatric haematologists may see one case in years. Our network connects them across continents for real-time case discussion. No child's outcome should depend on geography.

The iCMLf is inviting collaborators to join the iCMLf Cure Consortium (iC3) - a global initiative focused on achieving a cure for CML. Interested in collaborating? Contact 📩 info@cml-foundation.org to request the iC3 Prospectus and Expression of Interest form.

⏳ Last call – happening tomorrow Join us tomorrow, Tuesday 20 January, for the next iCMLf Conversation: Highlights of ASH 2025. 👉 Register now buff.ly/yBbQ4jE

CML doesn't discriminate, but access to treatment does. While patients in some countries have access to life-saving medications and cutting-edge care, millions of others face barriers that put their lives at risk. Help us bridge the gap: climb-for-a-cure.raiselysite.com